Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
14.6M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
13.3M
-
Shares change
-
+1.13M
-
Total reported value, excl. options
-
$483M
-
Value change
-
+$37.4M
-
Number of buys
-
40
-
Number of sells
-
-29
-
Price
-
$36.39
Significant Holders of Neurogene Inc. - Common Stock (NGNE) as of Q2 2024
81 filings reported holding NGNE - Neurogene Inc. - Common Stock as of Q2 2024.
Neurogene Inc. - Common Stock (NGNE) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 13.3M shares
of 14.6M outstanding shares and own 91.02% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.39M shares), EcoR1 Capital, LLC (1.27M shares), Samsara BioCapital, LLC (1.27M shares), RTW INVESTMENTS, LP (1.07M shares), Redmile Group, LLC (1.01M shares), GREAT POINT PARTNERS LLC (1M shares), JANUS HENDERSON GROUP PLC (835K shares), Avidity Partners Management LP (728K shares), VANGUARD GROUP INC (564K shares), and Casdin Capital, LLC (525K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.